Immunodiagnostic Systems Holdings plc provides earnings guidance for the six months ended 30 September 2013. Total revenues are expected to be £27 million representing 13% growth in revenues compared to the prior year equivalent period. The increase in revenue was driven by the continued growth in automated revenues of 37%, compared to the prior year period.